Brain Cancer Patients That Respond Better To Treatment May Be Identified By Gene Change

New research proves that a change in a particular gene can identify which patients with a specific kind of brain cancer will respond better to treatment. Testing for the gene can distinguish patients with a more- or less-aggressive form of glioblastoma, the most common and an often-fatal type of primary brain cancer, and help guide therapy, the researchers say. The prospective study looked at a gene called MGMT in tumors removed from 833 glioblastoma patients. It showed that when the gene promoter is altered by a chemical change called methylation, patients respond better to treatment...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/tudlwFent8c/227104.php

rehab sport sport medical